Back to discover
Drug

Kainic Acid

Research stage
Emerging researchSteady momentum
4
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Kainic Acid
RxNorm CUI
6093
ChEMBL ID
CHEMBL275040
UNII
SIV03811UC

Research activity

4 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
19972024
Major research themes7
Epilepsy, Temporal Lobe1Exosomes1HMGB1 Protein1Kainic Acid1MicroRNAs1Potassium Channels1Status Epilepticus1
Journals, researchers & institutions
Top journals
  • Communications biology1
  • eNeuro1
  • Molecular biology reports1
  • The Journal of neuroscience : the official journal of the Society for Neuroscience1
Leading researchers
  • Abe T1
  • Bernard C1
  • Bischof H1
  • Ehinger R1
  • Flor PJ1
  • Kinoshita A1
  • Liu H1
  • Liu T1
Leading institutions
free-text, unnormalised
  • Institute de Neurosciences des Systèmes1
  • Kyoto University1
  • Laboratory of Organic Electronics1
  • School of Medical Imaging1
  • The Second Affiliated Hospital of Xuzhou Medical University1
  • Toxicology and Clinical Pharmacy1

Related diseases

1 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Active research areas

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 4 of the same disease areas as Kainic Acid in the shared literature.

4 shared diseases1 shared paper

Frequently co-studied with Kainic Acid in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature